D-2-hydroxyglutarate interferes with HIF-1α stability skewing T-cell metabolism towards oxidative phosphorylation and impairing Th17 polarization

D-2-hydroxyglutarate (D-2HG) is released by various types of malignant cells including acute myeloid leukemia (AML) blasts carrying isocitrate dehydrogenase (IDH) gain-of-function mutations. D-2HG acting as an oncometabolite promotes proliferation, anoikis, and differentiation block of hematopoietic...

Descripción completa

Detalles Bibliográficos
Autores principales: Böttcher, Martin, Renner, Kathrin, Berger, Raffaela, Mentz, Kristin, Thomas, Simone, Cardenas-Conejo, Zugey Elizabeth, Dettmer, Katja, Oefner, Peter J., Mackensen, Andreas, Kreutz, Marina, Mougiakakos, Dimitrios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993507/
https://www.ncbi.nlm.nih.gov/pubmed/29900057
http://dx.doi.org/10.1080/2162402X.2018.1445454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993507/
https://www.ncbi.nlm.nih.gov/pubmed/29900057
http://dx.doi.org/10.1080/2162402X.2018.1445454

Ejemplares similares